Steven Bollipo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Early uncertainty about the safety of noninterferon antivirals in patients with liver cancer may have contributed to the slow acceptance of direct-acting antiviral agents in this population.

University of california san franciscoUnited statesPalo altoStanford universitySteven bollipoLeslie yeeman kamComoderator jenniferStanford university medical centerLiver meetingAmerican associationLiver diseasesClinformatics data martJohn hunter hospitalNew south walesMedscape medicalCalifornia san francisco